Pfizer Stock - Weekly sector check after pneumococcal vaccine update
19.06.2026 - 19:07:02 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 17:00 UTC. Details in the imprint.
Pfizer (US7170811035) remains one of the largest global drug makers by revenue and market value. The stock sits close to its 52-week lows while investors reassess the longer-term earnings base after the Covid vaccine windfall, according to recent Standard & Poor's 500 index data.
Background and price data on Pfizer stock
All news, filings and market data on Pfizer share performance and corporate actions can be found in the dedicated topic area on ad-hoc-news.de.
How Pfizer compares this week
Among big pharma names in the Standard & Poor's 500 index, Pfizer trades at a discount to peers such as Eli Lilly and Johnson & Johnson on forward earnings multiples, according to recent market data from major US exchanges.
The stock has been pressured by the sharp normalization of Covid revenues, while peers with stronger obesity or oncology pipelines have seen relatively more robust share performance over the past 12 months.
Weekly review and sector context
The broader US pharmaceuticals and biotechnology sector has shown mixed performance this week, with defensive healthcare demand offset by concerns over US drug pricing reforms and patent-expiry headwinds at several companies.
Against this backdrop, Pfizer shares have tracked the lower end of their recent trading range, mirroring the cautious tone across mature large-cap pharma that lack immediate blockbuster launches.
The product behind the stock
Pfizer generates revenue from a diversified portfolio of prescription medicines and vaccines, including its pneumococcal vaccine franchise Prevnar, oncology therapies and cardiovascular treatments, complemented by selected consumer healthcare partnerships.
Where the stock trades today
Pfizer stock trades on the New York Stock Exchange at $25.21 as of 06/19/2026, 16:00 ET.
Key facts on Pfizer stock
- Company: Pfizer Inc.
- ISIN: US7170811035
- WKN: 852009
- Ticker: PFE
- Venue: NYSE
- Price (as of 06/19/2026, 16:00 ET): 25.21 USD
- Market cap: 142,000,000,000 USD (as of 06/19/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: Standard & Poor's 500 index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
